In this conversation, we discuss the development of the European Pharma Eco-System, different business models generally accepted in the industry, and ...

Here is my conversation with Andrea Sommer about the advantages of patents for private deep-tech companies.Timestamps:For those who want to listen to ...

Here is my conversation with Kurt Hölller and Joy Cürten from EIT Health about the health tech revolution in Europe and the Rest of the World.Episode ...

Here is my conversation with Sebastien Groyer, Entrepreneur and Venture CapitalistEpisode Links:Article to the Episode: https://lsg2g.substack.com/p/7...

Here is my conversation with Wolfgang Kienreich, CBO of Know-Center.Episode Links:Article to the Episode: https://lsg2g.substack.com/p/46-an-introduct...

Here is my conversation with Jama Nateqi, CEO of Symptoma.Episode Links:Article to the Episode: https://lsg2g.substack.com/p/45-hidden-secrets-to-succ...

Here is the conversation with Tero Weckroth, Business Angel and Investment Expert from Finland about Public and Private Investments.Episode Links:Arti...

Thomas Moser and Tilmann Buerckstuemmer lead the Austrian Life Science Company Aelian Biotechnology.Episode Links:Article to the Episode: https://lsg2...

Have you ever wondered what role the small country Austria - located in the center of Europe - plays in Life Science?Then listen to the managing direc...

This episode will discuss what it takes to build companies that develop novel therapies, vaccines, and diagnostics in the pharma industry.Since the pa...